Celcuity Inc. Common Stock (CELC) is a publicly traded Healthcare sector company. As of September 1, 2026, CELC trades at $90.67 with a market cap of $4.33B and a P/E ratio of -23.31. CELC moved +1.57% today. Year to date, CELC is -10.71%; over the trailing twelve months it is +73.84%. Its 52-week range spans $7.58 to $151.02. Analyst consensus is strong buy with an average price target of $160.89. Rallies surfaces CELC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest CELC news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $90.67 |
| Market Cap | $4.33B |
| P/E Ratio | -23.31 |
| EPS | $-3.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $151.02 |
| 52-Week Low | $7.58 |
| Volume | 66.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-177.04M |
| Gross Margin | 0.00% |
10 analysts cover CELC: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $160.89.